Subscribe To
Why abbvie stock fell today
AbbVie stock fell today despite easily exceeding estimates for its third quarter. Revenue declines across AbbVie's immunology, ...
October 27, 2023, 3:06 pm
oncology drugs market set to hit $347.3 billion by 2032 driven by rising cancer prevalence: persistence market research
Increased investments in oncology medications and research, fueled by rising cancer prevalence, offer g...
October 27, 2023, 11:31 am
Why is transcode therapeutics (rnaz) stock down 25% today?
TransCode Therapeutics (NASDAQ: RNAZ ) stock is taking a beating on Friday after the oncology company ...
October 27, 2023, 8:16 am
Shareholder alert: levi & korsinsky, llp notifies shareholders of an investigation concerning possible breaches of fiduciary duty by certain officers and directors of pyxis oncology, inc. (nasdaq: pyx
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky announces that it has commenced an investigation of Pyxis ...
October 26, 2023, 6:27 pm
Apollomics announces report of activity of vebreltinib in glioblastoma multiforme (gbm) with ptprz-met fusion
FOSTER CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”), today announced a report by the Veneto Ins...
October 26, 2023, 12:50 pm
Aptose to report third quarter 2023 financial results and hold conference call on thursday, november 9, 2023
SAN DIEGO and TORONTO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision ...
October 26, 2023, 7:11 am
Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
Merck & Co. on Thursday reported third-quarter results that topped analysts' expectations, powered by growth in ...
October 26, 2023, 6:32 am
Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-...
October 25, 2023, 9:05 am
Why is lianbio (lian) stock up 130% today?
Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for cardiovascular, ...
October 24, 2023, 1:48 pm
Moderna and caris life sciences partner to develop mrna oncology therapeutics
Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and molecular science firm Caris Life Science...
October 24, 2023, 10:21 am
Bull of the day: neogenomics (neo)
NeoGenomics ( NEO ) is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive ...
October 24, 2023, 6:46 am
Merck & co. inc. (mrk) merck & co. announced collaboration with daiichi sankyo and esmo investor event (transcript)
Merck & Co. Inc. (NYSE:MRK ) October 22, 2023 1:00 PM ET Company Participants Peter Dannenbaum - VP, IR Dr. Dean Li - President, Merck Research Labs E...
October 23, 2023, 11:32 am
Astrazeneca boss pascal soriot dismisses exit talk
AstraZeneca PLC (LSE:AZN) boss Pascal Soriot has told Bloomberg that reports of his imminent departure from the drugmaker are “fake news.” Soriot...
October 23, 2023, 10:01 am
Potential of arvinas’ protac® ar degraders reinforced by 11.1 months rpfs with bavdegalutamide and updated positive interim data from second generation arv-766 in mcrpc
– Data presented at the European Society for Medical oncology from the Phase 1/2 trial with bavdegalu...
October 22, 2023, 11:00 am
Bristol-myers squibb acquisition of mirati makes sense
Bristol Myers Squibb is a large pharmaceutical company with a strong dividend yield and impressive assets. The company's recent acquisition of Mirati ...
October 22, 2023, 8:53 am
Olema oncology announces positive phase 2 monotherapy clinical study results for palazestrant
Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PF...
October 22, 2023, 6:55 am
Revolution medicines presents promising clinical activity and safety data from phase 1/1b trial of rmc-6236
Investor Webcast to be held Sunday, October 22 at 12:30 p.m. Eastern Time REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) — Revolution Medicine...
October 22, 2023, 6:30 am
Terns pharmaceuticals to participate in upcoming investor conferences
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
October 19, 2023, 8:05 pm
Maia biotechnology to present preliminary safety and efficacy data from thio-101 phase 2 clinical trial at european society for medical oncology congress 2023
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at ESMO Congress 202...
October 19, 2023, 8:35 am
Eli lilly is buying another european cancer firm mablink bioscience
Eli Lilly & Co (NYSE: LLY) is buying Mablink Bioscience – a French biotechnology company that focuses primarily on the next-generation, antibody-dru...
October 18, 2023, 10:01 am